Purchase Order 36C26222P1376
- Not listed
- The Veterans Integrated Service Network 8 awarded a purchase order to Qiagen, LLC for QIAGEN reagents on July 29, 2022, with a firm fixed-price ceiling value of $584,436 and an ultimate completion date of September 30, 2026. This contract, which was not designated as a set-aside, represents a direct procurement of specialized diagnostic reagents from Qiagen's extensive portfolio of molecular diagnostics products. Qiagen, LLC is a Germantown, Maryland-based subsidiary of Netherlands-headquartered...
- Qiagen, LLC was awarded a $80,343.09 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide Quantiferon TB reagents and supplies. As the prime contractor, Qiagen will deliver the requested products to support tuberculosis screening and diagnosis efforts at locations within the Germantown, Maryland area. No set-aside provisions were specified for this award placed against an unspecified...
- The Veterans Integrated Service Network 8 awarded a $217,834.65 firm fixed-price purchase order to Qiagen, LLC for QuantiFERON-TB Gold Plus reagents and controls. The contract, awarded April 16, 2024, with completion targeted for September 30, 2025, represents a task order issued under an existing blanket purchase agreement between Veterans Integrated Service Networks and Qiagen for tuberculosis testing supplies. This purchase order supports VA clinical laboratory operations and occupational...
- Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics and bioinformatics solutions, was awarded a $60,473.55 firm fixed price Blanket Purchase Agreement (BPA) call for QuantiFERON reagents under Veterans Integrated Service Network 19 on September 1, 2024. This is a child award issued under an existing BPA vehicle and represents one of multiple recurring task orders supporting the Department of Veterans Affairs' clinical laboratory operations. The award, with an ultimate...
- This is a Firm Fixed Price Delivery Order awarded by the Veterans Integrated Service Network 17, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract, valued at $106,687.50, is for the supply of QuantiFERON-TB Gold Plus reagents. It is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a period of performance through November 30, 2026. The contract does not have a set-aside designation. Qiagen,...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $18,498.00 contract is for the provision of reagents and supplies over a 7-month period ending on September 30, 2023. Qiagen is an established federal contractor, holding several indefinite delivery vehicles with agencies like the VA and Defense Health Agency to provide...
- This federal contract award was issued by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $35,436.45 contract is for the procurement of QuantiFERON reagents, which are used for tuberculosis testing. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order, with an ultimate completion date of August 31, 2028. Qiagen has provided similar...
- Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer based in Germantown, Maryland, received a $835.5K firm fixed-price Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network 22 (VISN 22) for tuberculosis testing reagents. The contract, awarded on December 9, 2025, with an ultimate completion date of December 8, 2026, represents a call against Qiagen's existing $2.56M BPA with the Veterans Integrated Service Network. The award carries no set-aside...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Qiagen, LLC, a division of the international provider Qiagen N.V., for QUANTIFERON TB GOLD PLUS REAGENT. The $150,394.42 contract has a completion date of September 30, 2023 and does not have a set-aside designation. Qiagen is a manufacturer of molecular diagnostic products and services that supports federal agencies' biomedical research, public health, and healthcare programs. The...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 22 of the U.S. Department of Veterans Affairs to Qiagen, LLC for the provision of QuantiFERON TB reagents. The contract has a ceiling value of $157,879.35 and a period of performance through March 31, 2017. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academia. Qiagen has provided a range...
Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics and scientific equipment, was awarded a $497,875.40 firm fixed-price purchase order by the Veterans Integrated Service Network 22 on June 6, 2022, with performance completing by August 5, 2023. This contract, which carries no set-aside designation, procures reagents to support clinical laboratory operations within the Department of Veterans Affairs. The award reflects Qiagen's established role as a critical supplier to the VA, where multiple Veterans Integrated Service Networks maintain blanket purchase agreements totaling over $5 million for tuberculosis testing reagents and diagnostic supplies including QuantiFERON TB Gold Plus assays. As a subsidiary of Qiagen N.V., a Netherlands-based multinational biotechnology company, Qiagen, LLC leverages its specialized expertise in molecular diagnostics to serve federal agencies across the Department of Health and Human Services, Department of Defense, and Department of Justice. The company's federal contract portfolio demonstrates consistent success in competitive procurements, with product offerings spanning DNA/RNA extraction kits, bioinformatics software, and laboratory consumables. This purchase order represents a task order or direct procurement under the broader framework of Qiagen's established relationships with the Veterans Health Administration for diagnostic testing support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($83k) | 4/7/26 | |
| P00002 | Funding Only Action | $100.0k | 8/22/23 | |
| P00001 | Exercise an Option | $82.9k | 6/6/23 | |
| Not listed | Not listed | $397.9k | 6/6/22 |